ID   COLO 526
AC   CVCL_X400
SY   Colo 526; COLO #526; Colorado 526
DR   Wikidata; Q54814121
RX   PubMed=3629545;
RX   PubMed=6277475;
RX   PubMed=9213340;
CC   Miscellaneous: Age of donor from archive documents of Moore G.E.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
RX   PubMed=3629545; DOI=10.1016/0049-3848(87)90273-8;
RA   Scarlett J.D., Thurlow P.J., Connellan J.M., Louis C.J.;
RT   "Plasma-dependent and -independent mechanisms of platelet aggregation
RT   induced by human tumour cell lines.";
RL   Thromb. Res. 46:715-726(1987).
//
RX   PubMed=6277475;
RA   Frampton R.J., Suva L.J., Eisman J.A., Findlay D.M., Moore G.E.,
RA   Moseley J.M., Martin T.J.;
RT   "Presence of 1,25-dihydroxyvitamin D3 receptors in established human
RT   cancer cell lines in culture.";
RL   Cancer Res. 42:1116-1119(1982).
//
RX   PubMed=9213340; DOI=10.1080/00313029700169844;
RA   Bradley C.J., Dauer R.J., Thurlow P.J., Connellan J.M.;
RT   "Characterization of platelet aggregation induced by the human
RT   carcinosarcoma Colo 526: role of platelet activation, tumor cell
RT   cytoskeleton and tumor cell plasma membrane.";
RL   Pathology 29:189-195(1997).
//